MUC5AC might contribute to the progression of pancreatic cancer by inducing adhesiveness and invasiveness in ECM via VEGF overexpression, indicating that MUC5AC may be a potentially target in the treatment of pancreatic cancer. This evidence concerns the gene VEGFA and pancreatic neoplasm.